Potential Therapeutic Candidates against Chlamydia pneumonia Discovered and Developed In Silico Using Core Proteomics and Molecular Docking and Simulation-Based Approaches

Chlamydia pneumonia, a species of the family Chlamydiacea, is a leading cause of pneumonia. Failure to eradicate C. pneumoniae can lead to chronic infection, which is why it is also considered responsible for chronic inflammatory disorders such as asthma, arthritis, etc. There is an urgent need to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadi, Roqayah H., Altammar, Khadijah A., Hassan, Mohamed M., Shater, Abdullah F., Saleh, Fayez M., Gattan, Hattan, Al-ahmadi, Bassam M., AlGabbani, Qwait, Mohammedsaleh, Zuhair M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223490/
https://www.ncbi.nlm.nih.gov/pubmed/35742569
http://dx.doi.org/10.3390/ijerph19127306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223490/
https://www.ncbi.nlm.nih.gov/pubmed/35742569
http://dx.doi.org/10.3390/ijerph19127306

Ejemplares similares